ontinued impact of, or new occurrences of, terrorist attacks in the New York greater metropolitan area and any actions that may be taken in anticipation or response, demographic changes, the Issuers' ability to limit fraud and inventory shrink, the results of the Issuers' legal proceedings and recalls of pharmaceutical products due to health concerns or other reasons.